Home/Filings/4/0000899243-21-004384
4//SEC Filing

Sachs Jessica 4

Accession 0000899243-21-004384

CIK 0001622229other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:19 PM ET

Size

9.8 KB

Accession

0000899243-21-004384

Insider Transaction Report

Form 4
Period: 2021-02-01
Sachs Jessica
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-01+400,000400,000 total
    Exercise: $9.10Exp: 2031-02-01Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001782545

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:19 PM ET
Size
9.8 KB